
Michelle Hessen, OD, discusses how cyclosporine ophthalmic solution 0.09% is safe to use in patients with dry eye, as well as where future research should turn.
Michelle Hessen, OD, discusses how cyclosporine ophthalmic solution 0.09% is safe to use in patients with dry eye, as well as where future research should turn.
Michelle Hessen, OD, spoke about the results of a new study evaluating the efficacy of cyclosporine ophthalmic solution 0.09% in patients with dry eye.
Advancements in ocular technology, teleretinal imaging, and low-vision aids, including artificial intelligence-powered smart glasses, were highlighted in research posters at the Southeastern Congress of Optometry 2025.
Attendees and experts from the Southeastern Educational Congress of Optometry (SECO) 2025 meeting highlight research and sessions they will take away.
Brianna Rhue, OD, FAAO, discusses the pitfalls of myopia treatment and accessibility of that treatment.
Effective communication, cultural competence, and patient advocacy are keys to overcoming language barriers in eye care, as highlighted in a presentation at the Southeastern Congress of Optometry 2025.
Brianna Rhue, OD, FAAO, discussed novel approaches to myopia management and how they can be implemented into clinical practice.
New anti–vascular endothelial growth factor (VEGF) therapies are improving retinal disease management by providing patients with more treatment options, optimizing timing, and introducing innovative administration methods.
Multimodal imaging is a useful tool in diagnosing and managing age-related macular degeneration (AMD), according to Julie Rodman, OD, MS, FAAO.
Nate Lighthizer, OD, FAAO, discusses laser therapy and how attendees at Southeastern Educational Congress of Optometry (SECO) 2025 got hands-on experience at the conference.
The effectiveness of laser peripheral iridotomy (LPI) in managing angle closure glaucoma is uncertain, with studies suggesting that phacoemulsification may provide better intraocular pressure control and long-term outcomes, as discussed at the Southeastern Congress of Optometry 2025.
Mile Brujic, OD, FAAO, discusses his new research being presented at the Southeastern Educational Congress of Optometry 2025 meeting concerning dry eye treatment.
Julie Rodman, OD, MS, FAAO, discusses how optical coherence tomography angiography (OCT-A) can be used to diagnose and manage diabetic retinopathy.
Artificial intelligence, surgical innovations, and wearable technology are transforming eye care, enhancing patient outcomes and clinical efficiency, as discussed during the keynote presentation at the Southeastern Congress of Optometry (SECO) 2025.
I. Benjamin Gaddie, OD, FAAO, summarized the best forms of treating and managing demodex blepharitis.
Selective laser trabeculoplasty, artificial intelligence–driven diagnostics, and new drug delivery systems are transforming glaucoma care and improving patient outcomes, according to a panel of experts.
Julie Rodman, OD, MS, FAAO, previewed the Southeastern Educational Congress of Optometry (SECO) 2025 meeting by speaking about her keynote session.
Attendees can expect insights on advancements in glaucoma care, myopia management, dry eye treatments, emerging technologies, ocular disease myths, oral medications, the impact of obesity on ocular health, and more at the Southeastern Congress of Optometry (SECO) 2025.
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.